|
CLCN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.25981513688612E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.00169999972933E-07 |
| Normal-vs-Stage2 |
2.061500E-02 |
| Normal-vs-Stage3 |
3.282000E-02 |
| Normal-vs-Stage4 |
3.096600E-01 |
| Stage1-vs-Stage2 |
7.588600E-01 |
| Stage1-vs-Stage3 |
9.080800E-01 |
| Stage1-vs-Stage4 |
7.982800E-01 |
| Stage2-vs-Stage3 |
7.621400E-01 |
| Stage2-vs-Stage4 |
7.208600E-01 |
| Stage3-vs-Stage4 |
8.919800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.77529945878075E-10 |
| Normal-vs-AfricanAmerican |
2.641300E-04 |
| Normal-vs-Asian |
2.511400E-01 |
| Caucasian-vs-AfricanAmerican |
6.460400E-01 |
| Caucasian-vs-Asian |
9.246800E-01 |
| AfricanAmerican-vs-Asian |
9.456000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.78219686073089E-11 |
| Normal-vs-Female |
1.373020E-04 |
| Male-vs-Female |
5.458000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.595800E-02 |
| Normal-vs-Extreme_Weight |
6.15489999999941E-05 |
| Normal-vs-Obese |
3.639000E-04 |
| Normal-vs-Extreme_Obese |
5.552200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.786600E-01 |
| Normal_Weight-vs-Obese |
2.984600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.635900E-02 |
| Extreme_Weight-vs-Obese |
9.822800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.074400E-01 |
| Obese-vs-Extreme_Obese |
2.286200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.141700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.5543999965526E-08 |
| Normal-vs-Age(61-80Yrs) |
2.63769999953034E-07 |
| Normal-vs-Age(81-100Yrs) |
6.198300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.038200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.846800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.654600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.303600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.461800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.066200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62481139653892E-12 |
| Normal-VS-Type2 PRCC |
1.695250E-01 |
| Normal-VS-KIRP CIMP |
2.179400E-01 |
| Normal-VS-Unclassified PRCC |
1.935800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.06060000027686E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.839000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.272190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.011200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.239420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.129600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.729800E-02 |
| Normal-vs-N1 |
4.395800E-02 |
| Normal-vs-N2 |
4.113000E-01 |
| N0-vs-N1 |
8.458600E-01 |
| N0-vs-N2 |
5.455400E-01 |
| N1-vs-N2 |
5.669000E-01 |
|
|
